{"schema_version":"secwatch.filing_event.v1","accession":"0001787306-23-000081","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2023-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.241579+00:00","generated_at":"2026-06-11T07:00:05.767603+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcutis CFO Scott Burrows resigns; former CFO John Smither named interim CFO","bullets":["Scott Burrows resigns as CFO effective Aug 31, 2023 to pursue external opportunity; no disagreement with company.","John Smither, Arcutis' first CFO (2019-2021), appointed interim CFO effective Aug 31, 2023.","Smither has over 25 years pharma finance experience, including CFO roles at Kythera, Unity, Sienna, and interim CFO at Kite.","Smither will serve as principal financial and accounting officer; compensation terms to be disclosed later.","Company has commenced search for permanent CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001787306-23-000081","json":"https://secwatch.observer/filing/0001787306-23-000081.json","markdown":"https://secwatch.observer/filing/0001787306-23-000081.md","text":"https://secwatch.observer/filing/0001787306-23-000081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/0001787306-23-000081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/arqt-20230815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T07:00:05.767603+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b6c2921db6","claim":"Scott Burrows resigned as chief financial officer at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"On August 15, 2023, Scott Burrows notified Arcutis Biotherapeutics, Inc. (the “Company”) of his decision to resign as chief financial officer of the Company, effective as of August 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/0001787306-23-000081-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"chief financial officer"}],"fact_type":"executive_change"},{"claim_id":"bb9c258ad2","claim":"John Smither was appointed as interim chief financial officer at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"The Company has commenced a search for a permanent chief financial officer and has appointed John Smither, who previously served as the Company’s chief financial officer from May 2019 until his retirement in March 2021, as interim chief financial officer, effective upon Mr. Burrows’ departure from the Company on August 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/0001787306-23-000081-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim chief financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}